- Home
- TRDA vs JRS Comparison
TRDA vs JRS Comparison
Compare TRDA & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- JRS
- Stock Information
- Founded
- TRDA 2016
- JRS 2001
- Country
- TRDA United States
- JRS United States
- Employees
- TRDA N/A
- JRS N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- JRS Finance/Investors Services
- Sector
- TRDA Health Care
- JRS Finance
- Exchange
- TRDA Nasdaq
- JRS Nasdaq
- Market Cap
- TRDA 233.5M
- JRS 241.3M
- IPO Year
- TRDA 2021
- JRS N/A
- Fundamental
- Price
- TRDA $5.55
- JRS $8.16
- Analyst Decision
- TRDA Strong Buy
- JRS
- Analyst Count
- TRDA 3
- JRS 0
- Target Price
- TRDA $25.67
- JRS N/A
- AVG Volume (30 Days)
- TRDA 313.7K
- JRS 86.6K
- Earning Date
- TRDA 11-04-2025
- JRS 01-01-0001
- Dividend Yield
- TRDA N/A
- JRS 8.87%
- EPS Growth
- TRDA N/A
- JRS N/A
- EPS
- TRDA N/A
- JRS N/A
- Revenue
- TRDA $79,476,000.00
- JRS N/A
- Revenue This Year
- TRDA N/A
- JRS N/A
- Revenue Next Year
- TRDA N/A
- JRS N/A
- P/E Ratio
- TRDA N/A
- JRS N/A
- Revenue Growth
- TRDA N/A
- JRS N/A
- 52 Week Low
- TRDA $4.93
- JRS $5.95
- 52 Week High
- TRDA $21.79
- JRS $8.00
- Technical
- Relative Strength Index (RSI)
- TRDA 52.22
- JRS 56.90
- Support Level
- TRDA $5.08
- JRS $8.08
- Resistance Level
- TRDA $5.49
- JRS $8.23
- Average True Range (ATR)
- TRDA 0.30
- JRS 0.08
- MACD
- TRDA 0.03
- JRS -0.01
- Stochastic Oscillator
- TRDA 72.11
- JRS 46.43
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.